LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

Search

Perrigo Co PLC

Fermé

SecteurSoins de santé

10.66 2.21

Résumé

Variation du prix de l'action

24h

Actuel

Min

10.35

Max

10.86

Chiffres clés

By Trading Economics

Revenu

1B

-390M

Ventes

-140M

969M

BPA

0.43

Rendement du dividende

10.5

Marge bénéficiaire

-40.229

Employés

8,100

EBITDA

1.4B

118M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+62.52% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

10.50%

2.38%

Prochains Résultats

5 août 2026

Date du Prochain Dividende

16 juin 2026

Date du Prochain Détachement de Dividende

28 août 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-79M

1.5B

Ouverture précédente

8.45

Clôture précédente

10.66

Sentiment de l'Actualité

By Acuity

39%

61%

118 / 344 Classement par Healthcare

Perrigo Co PLC Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

14 juil. 2025, 13:01 UTC

Acquisitions, Fusions, Rachats

Perrigo to Sell Dermacosmetics Business to KKR With Focus on Streamlining Company

14 juil. 2025, 12:33 UTC

Acquisitions, Fusions, Rachats

Perrigo: Business Generated About 5% of 2024 Adjusted Operating Income >PRGO

14 juil. 2025, 12:33 UTC

Acquisitions, Fusions, Rachats

Perrigo: Dermacosmetics Branded Business Generated About EUR125 Million Sales in 2024 >PRGO

14 juil. 2025, 12:32 UTC

Acquisitions, Fusions, Rachats

Perrigo: Deal Proceeds to Further Strengthen Balance Sheet >PRGO

14 juil. 2025, 12:31 UTC

Acquisitions, Fusions, Rachats

Perrigo: Deal Includes EUR300 Million Upfront Cash, Up to EUR27 Million Contingent Payments >PRGO

14 juil. 2025, 12:31 UTC

Acquisitions, Fusions, Rachats

Perrigo To Sell Dermacosmetics Branded Business to KKR Investment Vehicle >PRGO

14 juil. 2025, 12:30 UTC

Acquisitions, Fusions, Rachats

Perrigo Announces Agreement to Divest Dermacosmetics Business for Up to EUR327 Million

Comparaison

Variation de prix

Perrigo Co PLC prévision

Objectif de Prix

By TipRanks

62.52% hausse

Prévisions sur 12 Mois

Moyen 17 USD  62.52%

Haut 17 USD

Bas 17 USD

Basé sur 2 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

2 ratings

1

Achat

1

Maintien

0

Vente

Sentiment

By Acuity

118 / 344Classement par Soins de santé

Sentiment de l'Actualité

Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Perrigo Co PLC

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation, well-being, and weight management products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, Compeed Stops, XLS, Arterin, Davitamon, Apiserum, Abtei, and Nicorette brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
help-icon Live chat